The original description of metabolic surgery is "the treatment of any metabolic disease by surgical means". In this respect, splenectomy used for the treatment of hematological disorders like ITP, Idiopathic Thrombocytopenic Purpura, is accepted within the concept of metabolic surgery. However, when metabolic surgery is mentioned in clinical practice, what is meant is the treatment of non-morbidly obese type 2 diabetic patients with surgical procedures. To this end, the only surgical method applied to overweight type 2 diabetic patients from the start has been ileal transposition (IT) (7, 8) .
sity surgery also has a learning curve of its own and it is obvious that the reason of insuffi cient weight loss/weight regain problems occurring within the fi rst year after surgery is technical incompetency. However, long term follow-up results of the patients who have undergone gastric banding or sleeve gastrectomy prove that the main problem reveals itself fi ve years after surgery and one third of those patients require revision or additional surgical intervention (9) (10) (11) (12) . Gastric band is entirely a restrictive operation.
Sleeve gastrectomy is a restrictive procedure even though it causes changes in some digestive system hormones.
Any restriction on human kind fails eventually. Therefore, it comes as no surprise that restrictive surgical procedures fail as well. Surgical community should bear in mind that the most important criteria for long term success is to activate ileum based anorexigenic hormones (GLP-1, Peptide YY, Oxyntomodulin, and etc.) and to achieve this without causing malabsorption. What counts as surgical success is not mechanical restriction provided by a little pouch, tight anastomosis or narrow sleeve gastrectomy, but "Functional Restriction" achieved by the activation of satiety hormones since the feeling of hunger can be sated with hormones such as GLP-1, Peptide YY and oxyntomodulin which are secreted when food enters distal ileum. Members of the entire surgical community serving in the fi eld of metabolic and bariatric surgery should focus on activating these hormones by surgical means without causing malabsorption.
Which operation?
There are two published methods based upon this goal, which are ileal transposition (IT) and transit bipartition (TB) procedures. Both operations are performed laparoscopically together with a sleeve gastrectomy in order to reduce ghrelin levels, avoid peptic ulcers, decrease caloric intake and avoid gastric dilation (13) . However, these techniques utilize different strategies. IT maximizes distal gut activity interposing a segment of ileum right after the stomach and minimizes proximal activity excluding the duodenum (7, 8) .
TB enhances distal activity bringing the whole ileum to the antrum and diminishes proximal activity shifting food from the duodenal route, which is left intact, further minimizing malabsorption (and amplifying endoscopic access, instead of reducing it). Both procedures aim at functional (and not the mechanical) restriction, trying to avoid malabsorption, instead of having it as a benefi cial goal.
Ileal transposition: A challenging option?
IT associated with a diverted sleeve gastrectomy has been blamed for its complexity and named as a challenging operation. However, recently published evidence suggest that IT, compared to sleeve and bypass, has a slightly higher, but acceptable complication (6.1%) and mortality (0.27%) rates, and can be safely performed within the hands of well trained and dedicated teams (14) .
Ileal transposition: Do we really need it?
IT with diverted sleeve gastrectomy technique offers the possibility to provide us caloric restriction, duodenal exclu- (14) . (16, 17) .
PATHOPHYSIOLOGY of TYPE 2 DIABETES and IT

CLAMP STUDIES Insulin Sensitivity
Insulin sensitivity in clamp method is calculated as the 
Beta-Cell Function
Beta-cell function during MTT is resolved using a mathematical model describing the relationship between insulin secretion and glucose concentration. In brief, the model consists of three blocks: fi rstly, glucose concentration profi le is stabilized; secondly, dependence of insulin (or Cpeptide) secretion on glucose concentration is stabilized;
and thirdly, C-peptide kinetics are individually adjusted to the subject's anthropometric data.
Insulin Kinetics & Effi ciency
The dependence of insulin secretion rate on absolute glucose concentration at each time point during MTT is The dependence of insulin secretion rate on the rate of change of plasma glucose levels is denoted as rate sensitivity.
MECHANISMS of ACTION in IT
It has been previously documented that IT is associated with signifi cant increase in rate sensitivity, disposition index, glucose dependent C-peptide release, and insulin sensitivity index (Figures 2-5) . Furthermore, IT leads to signifi cant elevations in beta cell glucose sensitivity, insulin sensitivity, hepatic resistance index, and muscular sensitivity index (Figures 6-8 ).
WEIGHT LOSS
IT operation has been performed on a wide variety of pa- (14) . These data demonstrate that the more the preoperative excess weight, the more weight loss has been achieved by IT operation. This operation provides an early contact of ingested nutrients to the interposed distal ileum and an early and signifi cant rise of glucagon-like peptide is observed. This step corrects the defective early phase of insulin secretion and leads to prolonged satiety. 
SUMMARY
Bariatric and Metabolic Surgery is still an evolving concept and there will always be a search for "the best" technique.
Although BPD and DS provide the highest rates of remission in terms of weight control and glycemic regulation, they are still being practiced by less than 3% of the bariatric community since these techniques require a life-long multi drug supplementation and may eventually necessitate a revisional surgery. Theoretical steps of success in the fi eld of Bariatric & Metabolic Surgery are listed below (7, 8, 18) 
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